1. Home
  2. Labeler Index
  3. Nucare Pharmaceuticals,inc.
  4. 68071-4600
  5. Product Images: Carvedilol

Product Images Carvedilol

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 6 images provide visual information about the product associated with Carvedilol NDC 68071-4600 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

68071 4600 8

68071 4600 8

This is a label of Carvedilol 6.25mg tablets manufactured by NuCare Pharmaceuticals, Inc. It contains information about the product including the NDC number, lot number, and expiration date. The tablets are oval shaped, white/off-white in color with 'E' on one side and '02' on the other side. The label warns to keep the medicine out of reach of children and store it in a controlled temperature environment. It also instructs to contact a doctor for medical advice about side effects and reports to FDA if any side effects occur.*

Figure 1. Survival Analysis for COPERNICUS (Intent-to-Treat) - carvedilol fig1

Figure 1. Survival Analysis for COPERNICUS (Intent-to-Treat) - carvedilol fig1

Figure 2. Effects on Mortality for Subgroups in COPERNICUS - carvedilol fig2

Figure 2. Effects on Mortality for Subgroups in COPERNICUS - carvedilol fig2

This text provides a chart labeled Figure 2 that shows the effects on mortality for different subgroups in COPERNICUS. The subgroups include men, women, age less than 65 or equal to 65, non-black or black, diabetic or non-diabetic, ischemic or non-ischemic, those with a heart rate under 70 or higher, those with a systolic blood pressure (SBP) above 120 mm Hg or under 120 mm Hg, those taking spironolactone or not, and all patients. The chart displays hazard ratios on the y-axis from 0 to 20 and is divided into increments of 5. There is no additional usable information available.*

Figure 3. Survival Analysis for CAPRICORN (Intent-to-Treat) - carvedilol fig3

Figure 3. Survival Analysis for CAPRICORN (Intent-to-Treat) - carvedilol fig3

Figure 4. Effects on Mortality for Subgroups in CAPRICORN - carvedilol fig4

Figure 4. Effects on Mortality for Subgroups in CAPRICORN - carvedilol fig4

Chemical Structure - carvedilol str

Chemical Structure - carvedilol str

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.